UK advertising rules on bioresonance therapy: CAP advice, updated January 2026

Citation. Committee of Advertising Practice (2026). Bioresonance therapy. Advice online, ASA/CAP, updated 6 January 2026.

Type. Regulatory guidance for UK advertisers.

What it says. CAP has seen no evidence that bioresonance devices diagnose, prevent or treat disease, and objective claims of that kind need robust clinical evidence. Cites upheld ASA rulings against Life Principles (2015), Y and M Holistic Clinic (2018), Wayne Hardwick (2019) and Anthony Grant (2021). This is the rule book this site writes under, which is why every entry in the library describes rather than claims.

Read the original. https://www.asa.org.uk/advice-online/bioresonance-therapy.html

This entry describes what the regulator says. It is not a claim by this site that bioresonance diagnoses or treats any condition.

David Franklin

David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.

See Full Bio